1[1]Mclennan S,Fisher E,Martell S,et al.Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells:possible role in diabetic nephropathy[J].Kidney Int,2000,58(77):81.
2[2]Mignatti P.Extracellular matrix remodeling by metalloproteinases and plasminogen activators[J].Kidney Int,1995,47(49):12.
3[3]Baricos WH,Cortez SL,Dahr SSE,et al.ECM degradation by cultured human mesangial cells is mediated by PA/plasmin/MMP- 2 cascade[J]. Kidney Int,1995,47:1039.
4[4]Okada A,Tomasetto C,Lutz Y,et al.Expression of matrix metallopro- teinases during rat skin wound healing:evidence that membrance type- 1 matrix metalloproteinase is a stromal activator of pro- gel A[J].J Cell Biol,1997,137:67.
5[5]Baker AH,Zaltsman AB,George SJ,et al.Divergent effects of tissue in- hibitor of metalloproteinase- 1,2 or 3 overexpression on rat vascular smooth muscle cell invasion,proliferation,and death in vitro[J].J Clin Invest,1998,101:1478.
6[6]Suzuki D,Miyazaki M,Jinde K,et al.In site hybridization studies of matrix metalloproteinase- 3,tissue inhibitor of metalloproteinase- 1 and type IV collagen in diabetic nephropathy[J].Kidney Int,1997,52:111.
7[7]Del Prete D,Angliani F,Forino M,et al.Down regulation of glomerular matrix metalloproteinase- 2 gene in human NIDDM[J].Diabetologia, 1997,40:1449.
8[8]Schaefer L,Han X,August C,et al.Differential regulation of glomerular gelatinase B(MMP- 9) and tissue inhibitor of metalloproteinase- 1 (TIMP- 1) in obese zucker rats[J].Diabetologia,1997,40:1035.
9[9]Mclennan S,Yue DK,turtle JR.Effect of glucose on matrix metallopro- teinase acitivity in mesangial cells[J].Nephron,1998,79:293.
10[10]Esposito C,Liu ZH,Striker GE,et al.Inhibition of diabetic nephropathy by a GH antagonist:a molecular analysis[J].Kidney Int,1996,50:506.
